EU
Emory University Portfolio holdings
AUM
$27.7M
This Quarter Return
+16.78%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$126M
AUM Growth
+$126M
(+12%)
Cap. Flow
+$2.37M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
43.94%
Holding
59
New
7
Increased
24
Reduced
19
Closed
7
Top Buys
| 1 |
Puma Biotechnology
PBYI
|
$2.46M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$2.17M |
| 3 |
RXDX
Ignyta, Inc.
RXDX
|
$2.11M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$1.88M |
| 5 |
Trinity Industries
TRN
|
$1.83M |
Top Sells
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$2.74M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$1.89M |
| 3 |
NXTM
NxStage Medical Inc.
NXTM
|
$1.8M |
| 4 |
Armstrong World Industries
AWI
|
$1.65M |
| 5 |
Sarepta Therapeutics
SRPT
|
$1.58M |
Sector Composition
| 1 | Healthcare | 46.68% |
| 2 | Financials | 30.76% |
| 3 | Technology | 5.34% |
| 4 | Consumer Discretionary | 5.22% |
| 5 | Energy | 4.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.09T
| $32.1M | 25.44% | 117 | – | – |
|
|
ZGNX
2
DELISTED
Zogenix, Inc.
ZGNX
| $5.13M | 4.06% | 146,257 +27,938 | +24% | +$979K |
|
|
3
Puma Biotechnology
PBYI
$254M
| $2.46M | 1.95% | +20,555 | New | +$2.46M |
|
|
MYOV
4
DELISTED
Myovant Sciences Ltd.
MYOV
| $2.43M | 1.93% | 157,303 +28,075 | +22% | +$434K |
|
5
Alnylam Pharmaceuticals
ALNY
$58.5B
| $2.43M | 1.92% | 20,660 -922 | -4% | -$108K |
|
|
ONC
6
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $2.39M | 1.89% | 23,061 -18,248 | -44% | -$1.89M |
|
7
Ascendis Pharma
ASND
$11.8B
| $2.17M | 1.72% | 59,876 +421 | +0.7% | +$15.3K |
|
|
BHVN
8
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.17M | 1.71% | +57,938 | New | +$2.17M |
|
|
RXDX
9
DELISTED
Ignyta, Inc.
RXDX
| $2.11M | 1.67% | +170,507 | New | +$2.11M |
|
10
Wave Life Sciences
WVE
$1.53B
| $2.09M | 1.66% | 96,222 +22,202 | +30% | +$483K |
|
11
Amicus Therapeutics
FOLD
$2.34B
| $2M | 1.58% | 132,479 -69,878 | -35% | -$1.05M |
|
12
Acadia Pharmaceuticals
ACAD
$4.38B
| $2M | 1.58% | 52,977 -3,946 | -7% | -$149K |
|
|
SGEN
13
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.96M | 1.55% | 35,982 +12,278 | +52% | +$668K |
|
14
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.89M | 1.49% | 360,042 +72,492 | +25% | +$380K |
|
|
TSRO
15
DELISTED
TESARO, Inc.
TSRO
| $1.88M | 1.48% | +14,529 | New | +$1.88M |
|
16
Neurocrine Biosciences
NBIX
$13.8B
| $1.87M | 1.48% | 30,482 +1,166 | +4% | +$71.5K |
|
17
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.84M | 1.46% | 19,783 +2,453 | +14% | +$228K |
|
18
Travere Therapeutics
TVTX
$1.56B
| $1.84M | 1.46% | 73,917 -17,191 | -19% | -$428K |
|
|
LJPC
19
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.84M | 1.45% | 52,754 +5,401 | +11% | +$188K |
|
|
20
Trinity Industries
TRN
$2.3B
| $1.83M | 1.45% | +57,391 | New | +$1.83M |
|
21
Baker Hughes
BKR
$44.8B
| $1.76M | 1.39% | +48,027 | New | +$1.76M |
|
|
SMC
22
Summit Midstream Corporation
SMC
$282M
| $1.75M | 1.39% | 87,560 | – | – |
|
23
Neurogene
NGNE
$264M
| $1.75M | 1.38% | 123,250 +17,435 | +16% | +$247K |
|
|
GBT
24
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.74M | 1.38% | 56,157 +3,448 | +7% | +$107K |
|
|
WBC
25
DELISTED
WABCO HOLDINGS INC.
WBC
| $1.74M | 1.38% | 11,781 -1,166 | -9% | -$173K |
|